Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multi-antigen therapeutic HIV DNA vaccine - Profectus BioSciences

Next Previous
X
Search
Drug Profile

Multi-antigen therapeutic HIV DNA vaccine - Profectus BioSciences

Alternative Names: HIV MAG pDNA vaccine; PBX Vax™ prime/boost HIV; ProfectusVax DNA Plasmid HIV-1 nef/tat/vif, env; ProfectusVaxVSV IN HIV envC

Latest Information Update: 28 Aug 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Profectus Biosciences
  • Developer National Institute of Allergy and Infectious Diseases; Profectus Biosciences
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported HIV-1 infections

Most Recent Events

  • 28 Aug 2022 No recent reports of development identified for phase-I development in HIV-1-infections(Prevention, In volunteers) in USA (IM, Injection)
  • 12 Mar 2020 Phase-I development is ongoing in USA (NCT02654080)
  • 28 Aug 2019 No recent reports of development identified for phase-I development in HIV-1-infections in USA (IM, Injection)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top